These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 27567852)

  • 41. Subjective Cognitive Decline: Level of Risk for Future Dementia and Mild Cognitive Impairment, a Meta-Analysis of Longitudinal Studies.
    Pike KE; Cavuoto MG; Li L; Wright BJ; Kinsella GJ
    Neuropsychol Rev; 2022 Dec; 32(4):703-735. PubMed ID: 34748154
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Disentangling the relationship of subjective cognitive decline and depressive symptoms in the development of cognitive decline and dementia.
    Kleineidam L; Wagner M; Guski J; Wolfsgruber S; Miebach L; Bickel H; König HH; Weyerer S; Lühmann D; Kaduszkiewicz H; Luppa M; Röhr S; Pentzek M; Wiese B; Maier W; Scherer M; Kornhuber J; Peters O; Frölich L; Wiltfang J; Lewczuk P; Hüll M; Ramirez A; Jessen F; Riedel-Heller SG; Heser K
    Alzheimers Dement; 2023 May; 19(5):2056-2068. PubMed ID: 36218120
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activities of Daily Living and Depressive Symptoms in Patients with Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    Stogmann E; Moser D; Klug S; Gleiss A; Auff E; Dal-Bianco P; Pusswald G; Lehrner J
    J Alzheimers Dis; 2016; 49(4):1043-50. PubMed ID: 26577522
    [TBL] [Abstract][Full Text] [Related]  

  • 44. AD dementia risk in late MCI, in early MCI, and in subjective memory impairment.
    Jessen F; Wolfsgruber S; Wiese B; Bickel H; Mösch E; Kaduszkiewicz H; Pentzek M; Riedel-Heller SG; Luck T; Fuchs A; Weyerer S; Werle J; van den Bussche H; Scherer M; Maier W; Wagner M;
    Alzheimers Dement; 2014 Jan; 10(1):76-83. PubMed ID: 23375567
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Decline in the Incidence of All-Cause and Alzheimer's Disease Dementia: a 12-Year-Later Rural Cohort Study in Korea.
    Park JE; Kim BS; Kim KW; Hahm BJ; Sohn JH; Suk HW; Lee JY; Cho MJ
    J Korean Med Sci; 2019 Nov; 34(44):e293. PubMed ID: 31726496
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The impact of depressive symptoms on health-related quality of life in patients with subjective cognitive decline, mild cognitive impairment, and Alzheimer's disease.
    Pusswald G; Moser D; Pflüger M; Gleiss A; Auff E; Stögmann E; Dal-Bianco P; Lehrner J
    Int Psychogeriatr; 2016 Dec; 28(12):2045-2054. PubMed ID: 27576786
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Health-related quality of life in subjective cognitive decline and mild cognitive impairment: a longitudinal cohort analysis.
    Aye S; Bouteloup V; Tate A; Wimo A; Handels R; Jean D; Winblad B; Jönsson L
    Alzheimers Res Ther; 2023 Nov; 15(1):200. PubMed ID: 37968734
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A network approach to subjective cognitive decline: Exploring multivariate relationships in neuropsychological test performance across Alzheimer's disease risk states.
    Grunden N; Phillips NA; ;
    Cortex; 2024 Apr; 173():313-332. PubMed ID: 38458017
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A longitudinal study on quality of life along the spectrum of Alzheimer's disease.
    Mank A; Rijnhart JJM; van Maurik IS; Jönsson L; Handels R; Bakker ED; Teunissen CE; van Berckel BNM; van Harten AC; Berkhof J; van der Flier WM
    Alzheimers Res Ther; 2022 Sep; 14(1):132. PubMed ID: 36109800
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tactile Angle Discrimination Decreases due to Subjective Cognitive Decline in Alzheimer's Disease.
    Zhang Z; Chen G; Zhang J; Yan T; Go R; Fukuyama H; Wu J; Han Y; Li C
    Curr Alzheimer Res; 2020; 17(2):168-176. PubMed ID: 32148194
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Subjective cognitive decline predicts future deterioration in cognitively normal patients with Parkinson's disease.
    Hong JY; Sunwoo MK; Chung SJ; Ham JH; Lee JE; Sohn YH; Lee PH
    Neurobiol Aging; 2014 Jul; 35(7):1739-43. PubMed ID: 24507441
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessing the effectiveness of subjective cognitive decline plus criteria in predicting the progression to Alzheimer's disease: an 11-year follow-up study.
    Mazzeo S; Padiglioni S; Bagnoli S; Carraro M; Piaceri I; Bracco L; Nacmias B; Sorbi S; Bessi V
    Eur J Neurol; 2020 May; 27(5):894-899. PubMed ID: 32043740
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Subjective Cognitive Decline and its Relation to Verbal Memory and Sex in Cognitively Unimpaired Individuals from a Colombian Cohort with Autosomal-Dominant Alzheimer's Disease.
    Martinez JE; Pardilla-Delgado E; Guzmán-Vélez E; Vila-Castelar C; Amariglio R; Gatchel J; Aguirre-Acevedo DC; Bocanegra Y; Baena A; Henao E; Tirado V; Muñoz C; Giraldo-Chica M; Lopera F; Quiroz YT
    J Int Neuropsychol Soc; 2022 Jul; 28(6):541-549. PubMed ID: 34187609
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Olfactory deficits predict cognitive decline and Alzheimer dementia in an urban community.
    Devanand DP; Lee S; Manly J; Andrews H; Schupf N; Doty RL; Stern Y; Zahodne LB; Louis ED; Mayeux R
    Neurology; 2015 Jan; 84(2):182-9. PubMed ID: 25471394
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
    Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
    Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
    J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Subjective cognitive decline-related worries modulate the relationship between global amyloid load and gray matter volume in preclinical Alzheimer's disease.
    Wang X; Wang M; Wang X; Zhou F; Jiang J; Liu H; Han Y
    Brain Imaging Behav; 2022 Jun; 16(3):1088-1097. PubMed ID: 34743296
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Subjective Cognitive Decline as a predictor of Frailty in older adults: Hellenic Longitudinal Investigation of Aging and Diet study (HELIAD).
    Margioti E; Scarmeas N; Yannakoulia M; Dardiotis E; Hadjigeorgiou G; Sakka P; Ntanasi E; Aretouli E; Kosmidis MH
    J Frailty Aging; 2023; 12(3):198-207. PubMed ID: 37493380
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Motivational reserve: motivation-related occupational abilities and risk of mild cognitive impairment and Alzheimer disease.
    Forstmeier S; Maercker A; Maier W; van den Bussche H; Riedel-Heller S; Kaduszkiewicz H; Pentzek M; Weyerer S; Bickel H; Tebarth F; Luppa M; Wollny A; Wiese B; Wagner M;
    Psychol Aging; 2012 Jun; 27(2):353-63. PubMed ID: 21875213
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Altered Gut Microbiota in Adults with Subjective Cognitive Decline: The SILCODE Study.
    Sheng C; Lin L; Lin H; Wang X; Han Y; Liu SL
    J Alzheimers Dis; 2021; 82(2):513-526. PubMed ID: 34024839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.